Benefits
Greatly enhanced absorption
In a crossover study in 9 healthy men, NovaSOL produced more free curcumin in the blood than the two other formulations tested, reaching 6.7 to 38 nanomolar at 30 minutes. Worth knowing: those levels fell rapidly, and even the highest of them is roughly 100 times below the concentrations curcumin needs in laboratory dishes to do anything.
Inflammation: not measured in this product's study
The only published human study of NovaSOL measured curcumin levels in blood and stool. It did not measure inflammation, pain, or any other health outcome, so there is no evidence from this formulation that it calms inflammatory signaling in the body.
Joint comfort and recovery: no data on this product
No study of NovaSOL has looked at joints, stiffness, or exercise recovery. Claims in this area come from research on curcumin in general, not from this particular formulation.
Mechanism of action
Micellar solubilization
Curcumin is enclosed in surfactant micelles meant to keep it dissolved through digestion so more of it can cross the gut wall. This is a formulation strategy; the amount that actually reaches the blood as free curcumin is still small.
NF-kB and antioxidant pathways
In laboratory experiments, curcumin dampens NF-kB inflammatory signaling and supports antioxidant enzymes. Important caveat: the free curcumin levels measured in people after taking these formulations were about 100 times lower than the concentrations used in those laboratory experiments.
Clinical trials
A pharmacokinetic study and critical reappraisal of curcumin formulations sold as high absorption, including NovaSOL. The paper's central argument is that bioavailability claims for curcumin products are usually measured the wrong way. (Kroon et al. 2025, iScience)
9 healthy men, each taking the different formulations in turn (crossover design).
NovaSOL gave the highest free curcumin levels of the three formulations tested, 6.7 to 38 nanomolar at 30 minutes, beating Longvida head to head. Even so, across the study free curcumin stayed below 2 nanomolar in most samples, including at the higher dose and when piperine was added, and piperine gave no benefit. The authors put those levels at about 100 times lower than the concentrations used in laboratory work to show biological effects, and concluded that bioavailability claims should be based on free curcumin rather than on its poorly absorbed conjugates. Only blood and stool levels were measured; no health outcome was assessed.